Regencell Bioscience (RGC) has had the highest return since April 1, 2024 by a large-cap US stock, returning 20,954.7%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 20,954.73% |
Ast Spacemobile (ASTS) | 2,355.63% |
Rocket Lab USA (RKLB) | 1,610.65% |
Applovin (APP) | 934.52% |
Palantir Technologies (PLTR) | 721.19% |
Lumentum (LITE) | 721.12% |
Bloom Energy (BE) | 667.49% |
EchoStar (SATS) | 641.05% |
IREN (IREN) | 619.64% |
Credo Technology (CRDO) | 583.48% |
Celestica (CLS) | 573.23% |
Oklo (OKLO) | 564.82% |
Insmed (INSM) | 561.26% |
Nebius (NBIS) | 512.95% |
Robinhood Markets (HOOD) | 491.24% |
Carvana (CVNA) | 400.65% |
IAMGold (IAG) | 400.28% |
Ubiquiti Networks (UI) | 398.41% |
Guardant Health (GH) | 397.49% |
Ciena (CIEN) | 387.16% |
Kinross Gold (KGC) | 382.12% |
Carpenter Technology (CRS) | 371.75% |
GE Vernova LLC (GEV) | 368.27% |
Coeur Mining (CDE) | 368.05% |
Reddit (RDDT) | 361.23% |
Large-cap stocks are treated as having a market cap of $10B+.
